Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 5/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 5/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7082017 | 0.86 | NPC1 (0.79) | L3MBTL1CYP1A2CYP2C9CYP2C19RAB9A | |
| SCHEMBL14398436 | 0.85 | KDM4E (0.67) | L3MBTL1TDP1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL9787048 | 0.82 | L3MBTL1 (0.73) | L3MBTL1TDP1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL855090 | 0.82 | MAPT (0.78) | L3MBTL1TDP1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL8208699 | 0.80 | CYP1A2 (0.64) | L3MBTL1TDP1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL13550378 | 0.79 | ALDH1A1 (0.60) | L3MBTL1TDP1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL29112376 | 0.79 | CYP1A2 (0.67) | L3MBTL1CYP1A2CYP2C9CYP2C19RAB9A | |
| SCHEMBL83331 | 0.79 | RAB9A (0.79) | L3MBTL1TDP1RAB9ANPC1MAPT | |
| SCHEMBL2301959 | 0.78 | KMT2A (0.64) | L3MBTL1CYP1A2CYP2C9CYP2C19RAB9A | |
| SCHEMBL9422635 | 0.77 | MAPT (0.55) | L3MBTL1TDP1CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3104835-B1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2019-02-13 | — | — | EP | disclosed |
| US-9877484-B2 | Pulvurent effervescent topical treatment composition | RECKITT BENCKISER LLC (US) | 2018-01-30 | — | — | US | disclosed |
| US-20170006874-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2017-01-12 | — | — | US | disclosed |
| EP-3104835-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | Reckitt Benckiser LLC (US) | 2016-12-21 | — | — | EP | disclosed |
| WO-2015121659-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2015-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170006874-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | SOST, FPR2, SHH | L3MBTL1 3586/4885TDP1 4572/4885CYP1A2 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.